Inventor
SANDRA BERNDT
Inventor
DE
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides18%
C07DHeterocyclic compounds11%
A61NElectrotherapy7%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
B05BSpraying apparatus4%
PatentTitleYear
12,576,414Electrode arrangement for a rotary atomizer and associated operating method202612,144,865Antibody drug conjugates with enzymatically cleavable groups202412,065,497Methods of treatment using CCR8 antibodies202411,685,714Prodrugs of cytotoxic active agents having enzymatically cleavable groups202311,660,351Antibody drug conjugates (ADCs) having enzymatically cleavable groups202311,478,554Antibody drug conjugates (ADCS) having enzymatically cleavable groups202211,433,140Specific antibody drug conjugates (ADCs) having KSP inhibitors202211,427,640CCR8 antibodies for therapeutic applications202211,427,578Substituted pyrrolopyridine-derivatives2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to Bayer Pharma AG (6)· patent assignee history
2022–2024Patents assigned to BAYER AG (5)· patent assignee history
2022Patents assigned to BAYER HEALTHCARE LLC (1)· patent assignee history
2022Patents assigned to BAYER IP GMBH (1)· patent assignee history
2022Patents assigned to DEUTSCHES KREBSFORSCH (1)· patent assignee history
2022–2026Based in DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| Bayer Pharma AG | 6 | 2022–2024 |
| BAYER AG | 5 | 2022–2024 |
| BAYER HEALTHCARE LLC | 1 | 2022 |
| BAYER IP GMBH | 1 | 2022 |
| DEUTSCHES KREBSFORSCH | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 9 | 2022–2026 |